Profile of Saxagliptin in the Treatment of Type 2 Diabetes: Focus on Japanese Patients

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s46076
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Effect of Sitagliptin on Diabetic Profile of Type 2 Diabetes Mellitus Patients

International Journal of Contemporary Medical Research [IJCMR]
2019English

Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus

Journal of Clinical Medicine Research
2014English

Budget Impact Analysis of the Introduction of Saxagliptin/Metformin Extended-Release (Xr) in the Treatment of Type-2 Diabetes in Chile

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

A Study of Lipid Profile in Diabetes Mellitus Type-2 Patients

Journal of Medical Science And clinical Research
2019English

Health Care Resource Use and Costs in Patients With Type 2 Diabetes Mellitus After Treatment Initiation With Saxagliptin or Sitagliptin

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Emerging Treatments in Type 2 Diabetes: Focus on Canagliflozin

Therapeutics and Clinical Risk Management
2014English

Lipid Profile in Type 2 Diabetes

JMS SKIMS
2014English

Prevalence of Type 2 Diabetes Mellitus in Japanese Patients With Hepatocellular Carcinoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2010English

Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy